Brought to you by 
Ischemia Technologies raises $10.3mm in Series B financing
24 Jun 2005
Executive Summary
Ischemia Technologies (diagnostic medical devices focusing on ischemia) has grossed $10.3mm in a Series B financing of preferred stock. Initially the company had raised $6.8mm in November through the round, which was led by new investors Wolf Ventures and Murphree Ventures. Crawley Venture Group, also new, participated along with current investors Sequel Venture Partners, Quest Capital, and Roser Ventures and Piedmont Venture Partners. In December White Pines Ventures, Tenex Medical, and a European investor added another $3.5mm.
Deal Industry
- In Vitro Diagnostics
-
Medical Devices
- Diagnostic Equipment & Supplies
-
In Vitro Diagnostics
- Chemistry, Immunoassay
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Ischemia Technologies raises $10.3mm in Series B financing
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice